(Q34218148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

3

Chih-Chiang Chiu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Kuan-Pin Su

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Winston W Shen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

European Neuropsychopharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

267-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Polyunsaturated fatty acid deficit in patients with bipolar mania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Omega-3 fatty acids for depression in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Fish consumption and major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Brain cortex phospholipids liposomes effects on CSF HVA, 5-HIAA and on prolactin and somatotropin secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Eicosapentaenoic acid in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Are omega3 fatty acids beneficial in depression but not mania?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Fish consumption, depression, and suicidality in a general population

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900032-4

7 January 2021

10.1016/S0924-977X(03)00032-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888186%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference